Successful Placement of CDI’s Raises A$3.5 Million
TORONTO–(BUSINESS WIRE)–Almonty Industries Inc. (“Almonty” or the “Company”) (TSX: AII / ASX: AII / OTCQX:…
Year: 2023
Biogen Provides Update on FDA Advisory Committee Meeting on Tofersen for SOD1-ALS
SOD1-ALS is a rare genetic form of the disease affecting approximately 330 people in the…
CytomX Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results on March 27, 2023
SOUTH SAN FRANCISCO, Calif., March 22, 2023 (GLOBE NEWSWIRE) — CytomX Therapeutics, Inc. (Nasdaq: CTMX),…
Crypto.ro Announces Crypto Event ‘The Alliance’
TIMISOARA, Romania, Mar 23, 2023 – (ACN Newswire) – Crypto.ro, a leading online platform for…
Surprise Inside Chocolate Company Hatches Baby Animal Series Just in Time for Easter
CHICAGO, IL, Mar 23, 2023 – (ACN Newswire) – Yowie World is about to get…
FOXO Technologies Inc. Sets Fourth Quarter and Full Year 2022 Business Update Call for Thursday, March 30, 2023 at 3:15 p.m. CT
MINNEAPOLIS–(BUSINESS WIRE)–FOXO Technologies Inc. (NYSE_AM: FOXO), a leader in commercializing epigenetic biomarkers of health and…
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Boxed, Inc. (BOXD) on Behalf of Investors
LOS ANGELES–(BUSINESS WIRE)–Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm,…
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Rockwell Automation, Inc. (ROK) on Behalf of Investors
LOS ANGELES–(BUSINESS WIRE)–Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm,…
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Norfolk Southern Corporation (NSC) on Behalf of Investors
LOS ANGELES–(BUSINESS WIRE)–Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm,…
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Array Technologies, Inc. (ARRY) on Behalf of Investors
LOS ANGELES–(BUSINESS WIRE)–Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm,…
Tempest Reports Year End 2022 Financial Results and Provides Business Update
Positive monotherapy and combination therapy data from Phase 1 trial of first clinical program, TPST-1120,…
Cidara Therapeutics and Melinta Therapeutics Announce FDA Approval of REZZAYO™ (rezafungin for injection) for the Treatment of Candidemia and Invasive Candidiasis
– REZZAYO is a novel, once-weekly, next-generation echinocandin indicated for the treatment of candidemia and…
Senti Bio Reports Fourth Quarter and Full Year 2022 Financial Results and Reviews Recent Highlights
– SENTI-202 on track to submit an Investigational New Drug (IND) application in second half…
Context Therapeutics Reports Full Year 2022 Financial Results and Recent Pipeline Updates
Company prioritizing pipeline to focus on CTIM-76 development and discontinuing ONA-XR program Cash runway extended…
ERYTECH Provides Business and Financial Update for the Fourth Quarter and Full Year 2022
ERYTECH Provides Business and Financial Update for the Fourth Quarter and Full Year 2022 Combination…
Cyclerion Reports Corporate Update and Full Year 2022 Financial Results
CAMBRIDGE, Mass., March 22, 2023 (GLOBE NEWSWIRE) — Cyclerion Therapeutics, Inc. (Nasdaq: CYCN) today announced…
Invivyd Publishes Model for Evaluating Biomarker Correlates of Protection for Monoclonal Antibodies Against Symptomatic COVID-19
Research published online today in peer-reviewed journal Science Translational Medicine Analysis of data from a…
Infant Bacterial Therapeutics publishes Annual Report for 2022
Infant Bacterial Therapeutics AB (publ) publishes today the Annual Report for 2022. The report is…
89bio, Inc. Announces Proposed Underwritten Public Offering of Common Stock and Pre-Funded Warrants
SAN FRANCISCO, March 22, 2023 (GLOBE NEWSWIRE) — 89bio, Inc. (“89bio”) (Nasdaq: ETNB), a clinical-stage…
Kovo HealthTech Announces Letter of Intent for Strategic USD$10,300,000 Financing
Vancouver, British Columbia–(Newsfile Corp. – March 22, 2023) – Kovo HealthTech Corporation (TSXV: KOVO) (the…